OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stress-Induced Epstein-Barr Virus Reactivation
Daniel Sausen, Maimoona Bhutta, Elisa Gallo, et al.
Biomolecules (2021) Vol. 11, Iss. 9, pp. 1380-1380
Open Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Viral persistence, reactivation, and mechanisms of long COVID
Benjamin K. Chen, Boris Jülg, Sindhu Mohandas, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 143

Anti-viral triterpenes: a review
Priya Darshani, Shreya Sen Sarma, Amit Kumar Srivastava, et al.
Phytochemistry Reviews (2022) Vol. 21, Iss. 6, pp. 1761-1842
Open Access | Times Cited: 54

Acute and post-acute sequelae of SARS-CoV-2 infection: a review of risk factors and social determinants
Chumeng Wang, Akshara Ramasamy, Monica Verduzco‐Gutierrez, et al.
Virology Journal (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 35

Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients
Keishanne Danielle E. Bernal, Christopher B. Whitehurst
Virus Research (2023) Vol. 334, pp. 199157-199157
Open Access | Times Cited: 30

EBV and Lymphomagenesis
Daniel Sausen, Ayeman Basith, Syed Muqeemuddin
Cancers (2023) Vol. 15, Iss. 7, pp. 2133-2133
Open Access | Times Cited: 26

How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection
Guo‐Long Bu, Chu Xie, Yinfeng Kang, et al.
Viruses (2022) Vol. 14, Iss. 11, pp. 2372-2372
Open Access | Times Cited: 34

Long COVID: what is known and what gaps need to be addressed
Benjamin A. Krishna, Mark R. Wills, Nyaradzai Sithole
British Medical Bulletin (2023) Vol. 147, Iss. 1, pp. 6-19
Open Access | Times Cited: 17

Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
Karine Eid, Marte‐Helene Bjørk, Nils Erik Gilhus, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1520-1520
Open Access | Times Cited: 6

Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus
Chung‐Jen Chen
Taiwanese Journal of Obstetrics and Gynecology (2024) Vol. 63, Iss. 2, pp. 161-164
Open Access | Times Cited: 6

Can the Epstein–Barr Virus Play a Role in the Development of Prostate Cancer?
Jacek Kiś, Magdalena Góralczyk, Dominika Sikora, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 328-328
Open Access | Times Cited: 5

Building a Bridge Between the Mechanism of EBV Reactivation and the Treatment of EBV‐Associated Cancers
Jialin Jiang, Xinlei Zhu, Shukun Li, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 2
Closed Access

Anti-HLA antibodies may be a subset of polyreactive immunoglobulins generated after viral superinfection
S. Heron, J. H. F. Shaw, Johannes Dapprich
Transplant Immunology (2025), pp. 102197-102197
Open Access

Drought-compounded stress and immune function in Kenyan pastoralist boys and girls occupying contrasting climate zones
Bilinda Straight, Charles E. Hilton, Charles Owuor Olungah, et al.
Annals of Human Biology (2025) Vol. 52, Iss. 1
Open Access

Unveiling the Puzzle: Reactivated Epstein-Barr Virus-Associated Pancreatitis in a Young Adult
Michael K Coffin, Michael Zatoulovski, Zulfiya Tashpulatova, et al.
Cureus (2025)
Open Access

Virus-specific antibody responses in severe acute respiratory syndrome coronavirus 2-infected and vaccinated individuals
Nicole Hartwig Trier, Nadia Zivlaei, Sisse Rye Ostrowski, et al.
Immunology Letters (2025), pp. 107004-107004
Closed Access

Emerging drugs for Epstein-Barr virus associated-diseases
Nassima Oumata, Qian Zhong, Yongmin Zhang, et al.
European Journal of Medicinal Chemistry (2025), pp. 117386-117386
Closed Access

A Case of Persistent KSHV Viremia in the Context of HIV, SARS-CoV-2, and Other Co-Infections
Humaira Lambarey, Melissa J. Blumenthal, Prishanta Chinna, et al.
Tropical Medicine and Infectious Disease (2025) Vol. 10, Iss. 2, pp. 53-53
Open Access

Epstein–Barr Virus (EBV) Epithelial Associated Malignancies: Exploring Pathologies and Current Treatments
Oren Shechter, Daniel Sausen, Elisa S. Gallo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14389-14389
Open Access | Times Cited: 18

Virus-Derived Small RNAs and microRNAs in Health and Disease
Vasileios Gouzouasis, Spyros Tastsoglou, Antonis Giannakakis, et al.
Annual Review of Biomedical Data Science (2023) Vol. 6, Iss. 1, pp. 275-298
Open Access | Times Cited: 10

EBV-induced T-cell responses in EBV-specific and nonspecific cancers
Qiuting Zhang, Miao Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9

Understanding the Mode of Action of a Micro-Immunotherapy Formulation: Pre-Clinical Evidence from the Study of 2LEBV® Active Ingredients
Camille Jacques, Flora Marchand, Mathias Chatelais, et al.
Life (2024) Vol. 14, Iss. 1, pp. 102-102
Open Access | Times Cited: 3

Page 1 - Next Page

Scroll to top